%0 Journal Article
%T Safety and tolerability of IRL790 in Parkinson¡¯s disease with levodopa-induced dyskinesia¡ªa phase 1b trial
%A Anders Johansson
%A Clas Sonesson
%A Dag Nyholm
%A Fredrik Hansson
%A Joakim Tedroff
%A Panagiota Tsitsi
%A Per Svenningsson
%J Archive of "NPJ Parkinson's Disease".
%D 2018
%R 10.1038/s41531-018-0071-3
%X Overview of trial profil
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283839/